Antibacterial drug ‘clofoctol’ may counter coronavirus, research from the Pasteur Institute in Lille suggests

Where Industry Meet Trends

Clofoctol, an antibacterial drug, may be a potential treatment for SARS-CoV-2 virus, suggests the Pasteur Institute in Lille, France. The existing drug is currently used for bacterial respiratory tract infections and infections caused after nose, throat, or ear surgeries. Head of the Center for Infection and Immunity of Lille, Dr. Jean Dubuisson, informs that clofoctol has the potential to run a clinical trial because evidence suggests that it has anti-SARS-CoV-2 properties.

Leave a Reply Cancel reply

Welcome to Industry Trends, your go-to platform for insights and updates on the transformative power of AI and Automation across major industries. Our blog focuses on exploring the latest advancements, disruptions, and innovations shaping the future of Retail, Consumer Goods, Finance, Healthcare, and Manufacturing.

At Industry Trends, we are committed to delivering in-depth analysis, thought-provoking articles, and actionable strategies to help businesses and professionals stay ahead in today’s rapidly evolving digital landscape. Whether it’s the rise of intelligent automation in manufacturing, AI-driven personalization in retail, revolutionary changes in consumer goods, or the latest breakthroughs in healthcare and finance, we bring you the stories that matter the most.

Join us as we delve into the future of these industries and uncover how cutting-edge technology is redefining the way we work, live, and interact. Stay informed, stay inspired, and stay prepared with Industry Trends—where industries meet the power of innovation.

English